Gülay ÖZCENGİZ

Prof. Dr. Gülay ÖZCENGİZ


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Biochemical Pharmacology
Verified
Journal Article
Closed access
ÇYÇiğdem Yılmaz
Çiğdem Yılmaz
GÖGülay ÖZCENGİZ
Gülay ÖZCENGİZ

1 December 2015 in New Biotechnology
Verified
Journal Article
Closed access
GÖGülay ÖZCENGİZ
Gülay ÖZCENGİZ
IÖİsMail Öğülür
İsMail Öğülür

7 March 2006 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
OAOya Akçelik
Oya Akçelik
ÇTÇaǧla Tükel
Çaǧla Tükel
GÖGülay ÖZCENGİZ
Gülay ÖZCENGİZ
MAMustafa Akçelik
Mustafa Akçelik

18 April 2007 in Proteomics
Verified
Journal Article
Closed access
PDF file
SÖServet Özcan
Servet Özcan
VYVolkan Yıldırım
Volkan Yıldırım
LKLevent Kaya
Levent Kaya
DADirk Albrecht
Dirk Albrecht
DBDörte Becher
Dörte Becher
GÖGülay ÖZCENGİZ
Gülay ÖZCENGİZ

1 December 1991 in Folia Microbiologica
Verified
Journal Article
Closed access
PDF file
GÖGülay ÖZCENGİZ
Gülay ÖZCENGİZ
NAN. G. Alaeddinoglu
N. G. Alaeddinoglu

1 March 2017 in Synthetic and Systems Biotechnology
Verified
Journal Article
Open access
EÜEser Ünsaldı
Eser Ünsaldı
AKAslıhan Kurt-Kızıldoğan
Aslıhan Kurt-Kızıldoğan
BVBirgit Voigt
Birgit Voigt
DBDörte Becher
Dörte Becher
GÖGülay ÖZCENGİZ
Gülay ÖZCENGİZ
The usefulness of genetic/metabolic engineering for further improvement of industrial strains is subject of discussion because of the general lack of knowledge on genetic alterations introduced by iterative cycles of random mutagenesis in such strains. An industrial clavulanic acid (CA)-overproducer Streptomyces clavuligerus DEPA was assessed to understand proteome-wide changes that have occurred in a local industrial CA overproducer developed through succesive mutagenesis programs. The proteins that could be identified corresponded to 33 distinct ORFs for underrepresented ones and 60 ORFs for over-represented ones. Three CA biosynthetic enzymes were overrepresented in S. clavuligerus DEPA; carboxyethylarginine synthase (Ceas2), clavaldehyde dehydrogenase (Car) and carboxyethyl-arginine betalactam- synthase (Bls2) whereas the enzymes of two other secondary metabolites were underrepresented along with two important global regulators [two-component system (TCS) response regulator (SCLAV_2102) and TetR-family transcriptional regulator (SCLAV_3146)] that might be related with CA production and/or differentiation. gamma-butyrolactone biosynthetic protein AvaA2 was 2.6 fold underrepresented in S. clavuligerus DEPA. The levels of two glycolytic enzymes, 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase and phosophoglycerate kinase were found decreased while those of dihydrolipoyl dehydrogenase (E3) and isocitrate dehydrogenase, with two isoforms were found as significantly increased. A decrease of amino acid metabolism, methionine biosynthesis in particular, as well as S-adenosylmethionine synthetase appeared as one of the prominent mechanisms of success of S. clavuligerus DEPA strain as a prolific producer of CA. The levels of two enzymes of shikimate pathway that leads to the production of aromatic amino acids and aromatic secondary metabolites were also underrepresented. Some of the overrepresented stress proteins in S. clavuligerus DEPA included polynucleotide phosphorylase/polyadenylase (PNPase), ATP-dependent DNA helicase, two isoforms of an anti-sigma factor and thioredoxin reductase. Downregulation of important proteins of cell wall synthesis and division was recorded and a protein with beta-lactamase domain (SCLAV_p1007) appeared in 12 isoforms, 5 of which were drastically overrepresented in DEPA strain. These results described herein provide useful information for rational engineering to improve CA production in Streptomyces clavuligerus. (c) 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).